Emergent BioSolutions Reports Second Quarter and Six Months 2017 Financial Results; Reaffirms Calendar Year 2017 Guidance
Go back to Emergent BioSolutions Reports Second Quarter and Six Months 2017 Financial Results; Reaffirms Calendar Year 2017 Guidance| EMERGENT BIOSOLUTIONS, Inc. (NYSE: EBS) | Delayed: 6.21 -0.02 (0.32%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $6.23 | 52 Week High | $44.38 | |||
| Open | $6.26 | 52 Week Low | $24.47 | |||
| Day High | $6.30 | P/E | 310.50 | |||
| Day Low | $6.14 | EPS | $0.02 | |||
| Volume | 998,575 | |||||
